Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Jansen

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Infectious Diseases|February 16, 2021
The Mosaic mtr Locus as Major Genetic Determinant of Azithromycin Resistance of Neisseria gonorrhoeae-Germany, 2018Sebastian Banhart, Regina Selb, Sandra Oehlmann, et al.
BMC Infectious Diseases|October 28, 2016
Prevalence of Chlamydia trachomatis infection in women, heterosexual men and MSM visiting HIV counselling institutions in North Rhine-Westphalia, Germany - should Chlamydia testing be scaled up?Anne Lallemand, Viviane Bremer, Klaus Jansen, et al.
Journal of the International AIDS Society|October 5, 2019
Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional studyUwe Koppe, Ulrich Marcus, Stefan Albrecht, et al.
BMC Public Health|January 20, 2021
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in GermanyUwe Koppe, Ulrich Marcus, Stefan Albrecht, et al.
BMC Infectious Diseases|August 27, 2018
Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in GermanyAlexandra Sarah Lang, Matthias An der Heiden, Klaus Jansen, et al.
Human Vaccines & Immunotherapeutics|July 25, 2023
High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in GermanyAllahna L Esber, Hendrik Streeck, Klaus Jansen, et al.
Vaccine: X|May 2, 2023
Preparing for future European efficacy trials of interventions to prevent HIV and other sexually transmitted infections: Lessons on willingness to participate and barriers to participation from ten German clinics serving behaviorally vulnerable men who have sex with menAllahna L Esber, Klaus Jansen, Julie Dorsey-Spitz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 6, 2021
Markedly decreasing azithromycin susceptibility of <i>Neisseria gonorrhoeae</i>, Germany, 2014 to 2021Regina Selb, Susanne Buder, Sandra Dudareva, et al.
Emerging Infectious Diseases|April 30, 2013
Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, GermanyKarin Haar, Sandra Dudareva-Vizule, Hilmar Wisplinghoff, et al.
BMC Public Health|June 6, 2022
Prevalence of Chlamydia trachomatis in the general population in Germany - a triangulation of data from two population-based health surveys and a laboratory sentinel systemMartyna Gassowski, Christina Poethko-Müller, Martin Schlaud, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|February 16, 2021
The Mosaic mtr Locus as Major Genetic Determinant of Azithromycin Resistance of Neisseria gonorrhoeae-Germany, 2018Sebastian Banhart, Regina Selb, Sandra Oehlmann, et al.
BMC Infectious Diseases|October 28, 2016
Prevalence of Chlamydia trachomatis infection in women, heterosexual men and MSM visiting HIV counselling institutions in North Rhine-Westphalia, Germany - should Chlamydia testing be scaled up?Anne Lallemand, Viviane Bremer, Klaus Jansen, et al.
Journal of the International AIDS Society|October 5, 2019
Factors associated with the informal use of HIV pre-exposure prophylaxis in Germany: a cross-sectional studyUwe Koppe, Ulrich Marcus, Stefan Albrecht, et al.
BMC Public Health|January 20, 2021
Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in GermanyUwe Koppe, Ulrich Marcus, Stefan Albrecht, et al.
BMC Infectious Diseases|August 27, 2018
Not again! Effect of previous test results, age group and reason for testing on (re-)infection with Chlamydia trachomatis in GermanyAlexandra Sarah Lang, Matthias An der Heiden, Klaus Jansen, et al.
Human Vaccines & Immunotherapeutics|July 25, 2023
High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in GermanyAllahna L Esber, Hendrik Streeck, Klaus Jansen, et al.
Vaccine: X|May 2, 2023
Preparing for future European efficacy trials of interventions to prevent HIV and other sexually transmitted infections: Lessons on willingness to participate and barriers to participation from ten German clinics serving behaviorally vulnerable men who have sex with menAllahna L Esber, Klaus Jansen, Julie Dorsey-Spitz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 6, 2021
Markedly decreasing azithromycin susceptibility of <i>Neisseria gonorrhoeae</i>, Germany, 2014 to 2021Regina Selb, Susanne Buder, Sandra Dudareva, et al.
Emerging Infectious Diseases|April 30, 2013
Lymphogranuloma venereum in men screened for pharyngeal and rectal infection, GermanyKarin Haar, Sandra Dudareva-Vizule, Hilmar Wisplinghoff, et al.
BMC Public Health|June 6, 2022
Prevalence of Chlamydia trachomatis in the general population in Germany - a triangulation of data from two population-based health surveys and a laboratory sentinel systemMartyna Gassowski, Christina Poethko-Müller, Martin Schlaud, et al.
Pageof 6